Victor Esch

Victor Esch has over 20 years of experience successfully leading small companies, from very early stage through product introduction and company liquidity events, with a strong emphasis on technology and product development. Most recently, he was CEO of nanoMR, which introduced a highly sensitive sample prep technology for identifying causative pathogens in early stage sepsis. nanoMR was acquired by DNA Electronics (London, UK) in 2015. His first start-up experience was as Director of Research and Development at Indigo Medical, responsible for overseeing all product development for an interstitial laser treatment system for BPH. Indigo was acquired by Johnson & Johnson in 1996. He served as CTO of EndoVasix, a company that produced a laser based ischemic stroke treatment system. EndoVasix was acquired by W.L. Gore in 2006. He was a founder and the technology inventor at PowerVision, a medical device company that successfully developed an accommodating intraocular lens. PowerVision was sold to Alcon in 2019 for $285M. Victor has over 40 issued patents and his design innovations have been honored by R&D 100 and Photonics Circle of Excellence. He earned his Ph.D. in Optical Sciences from the University of Arizona.